Unless expressly stated otherwise in the authorisation to open provided for in Article R. 5124-6, a pharmaceutical establishment benefiting from an authorisation granted under 5° of Article R. 5124-2 also benefits from authorisations granted under 6° of the same article, with the exception of intermediate products.